IPHA logo

Innate Pharma SA (IPHA) Total Liabilities

Annual Total Liabilities

$146.24 M
-$18.61 M-11.29%

31 December 2023

IPHA Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$131.52 M
-$14.71 M-10.06%

30 June 2024

IPHA Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IPHA Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.3%-14.3%
3 y3 years-21.5%-16.7%
5 y5 years-55.0%-

IPHA Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-21.5%at low-27.4%at low
5 y5 years-55.0%at low-36.2%at low
alltimeall time-55.0%+2527.5%-59.5%+627.4%

Innate Pharma SA Total Liabilities History

DateAnnualQuarterly
June 2024
-
$131.52 M(-10.1%)
Dec 2023
$146.24 M(-11.3%)
$146.24 M(-4.7%)
June 2023
-
$153.43 M(-6.9%)
Dec 2022
$164.84 M(-9.0%)
$164.84 M(-3.8%)
June 2022
-
$171.41 M(-5.4%)
Dec 2021
$181.22 M(-2.7%)
$181.22 M(+14.8%)
June 2021
-
$157.86 M(-15.3%)
Dec 2020
$186.27 M(-9.6%)
$186.27 M(+32.2%)
June 2020
-
$140.92 M(-31.6%)
Dec 2019
$206.05 M(-36.6%)
$206.05 M(+5.8%)
June 2019
-
$194.76 M(-40.0%)
Dec 2018
$324.84 M(+60.2%)
$324.84 M(+102.5%)
June 2018
-
$160.42 M(-20.9%)
Dec 2017
$202.83 M(-1.8%)
$202.83 M(-0.1%)
June 2017
-
$203.02 M(-1.7%)
Dec 2016
$206.58 M(-19.2%)
$206.58 M(-12.9%)
June 2016
-
$237.10 M(-7.3%)
DateAnnualQuarterly
Dec 2015
$255.71 M(+1209.0%)
$255.71 M(-3.4%)
June 2015
-
$264.59 M(+1254.5%)
Dec 2014
$19.53 M(-9.3%)
$19.53 M(-22.4%)
June 2014
-
$25.17 M(+16.9%)
Dec 2013
$21.54 M(-34.7%)
$21.54 M(-18.8%)
June 2013
-
$26.51 M(-19.6%)
Dec 2012
$32.97 M(-24.0%)
$32.97 M(-15.0%)
June 2012
-
$38.78 M(-10.6%)
Dec 2011
$43.37 M(+125.0%)
$43.37 M(+125.4%)
June 2011
-
$19.24 M(-0.2%)
Dec 2010
$19.28 M(-21.2%)
$19.28 M(+6.6%)
June 2010
-
$18.08 M(-26.0%)
Dec 2009
$24.45 M(-10.4%)
$24.45 M
Dec 2008
$27.28 M(+38.0%)
-
Dec 2007
$19.77 M(+16.3%)
-
Dec 2006
$17.00 M(+205.5%)
-
Dec 2005
$5.57 M
-

FAQ

  • What is Innate Pharma SA annual total liabilities?
  • What is the all time high annual total liabilities for Innate Pharma SA?
  • What is Innate Pharma SA annual total liabilities year-on-year change?
  • What is Innate Pharma SA quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Innate Pharma SA?
  • What is Innate Pharma SA quarterly total liabilities year-on-year change?

What is Innate Pharma SA annual total liabilities?

The current annual total liabilities of IPHA is $146.24 M

What is the all time high annual total liabilities for Innate Pharma SA?

Innate Pharma SA all-time high annual total liabilities is $324.84 M

What is Innate Pharma SA annual total liabilities year-on-year change?

Over the past year, IPHA annual total liabilities has changed by -$18.61 M (-11.29%)

What is Innate Pharma SA quarterly total liabilities?

The current quarterly total liabilities of IPHA is $131.52 M

What is the all time high quarterly total liabilities for Innate Pharma SA?

Innate Pharma SA all-time high quarterly total liabilities is $324.84 M

What is Innate Pharma SA quarterly total liabilities year-on-year change?

Over the past year, IPHA quarterly total liabilities has changed by -$21.91 M (-14.28%)